Search

for
Search:

Research

5 / 1000+ results

1 citations , April 2025 in “Skin Health and Disease”

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

5 citations , January 2021 in “Inflammatory Bowel Diseases”

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

4 citations , January 2023 in “Skin health and disease”

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

63 citations , April 2018 in “Journal of the American Academy of Dermatology”

Topical JAK inhibitors may help treat some skin conditions but need more research.

January 2024 in “Journal of Crohn's and colitis”

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

2 / 801 results

a JAK inhibitor for alopecia areata and other autoimmune conditions

— no results

— no results

— no results